Explore Bronchogen dosage trends, reconstitution volumes, and vial size patterns from anonymized WPA peptide calculator sessions. Real-world bronchopulmonary peptide bioregulator mixing data.
Bronchogen is a short synthetic peptide bronchopulmonary bioregulator (Ala-Glu-Asp-Leu, AEDL) from the Khavinson family of organ-specific peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology, studied in Russian-language literature for its proposed regulatory effect on bronchial and lung epithelial tissue. This data shows the dose amounts, vial sizes, and diluent volumes researchers most commonly select when reconstituting Bronchogen.
Bronchogen is a synthetic Ala-Glu-Asp-Leu (AEDL) tetrapeptide from the Khavinson program, sourced for bronchial/pulmonary-tissue and aging research. It ships as a lyophilized powder you reconstitute before use, so the real vendor difference is what the certificate of analysis (COA) shows.
In the Khavinson framework, Bronchogen is proposed to act through direct binding to gene-promoter DNA in bronchial epithelial cells, selectively modulating transcription of genes involved in mucosal repair, ciliated-cell turnover, and antioxidant defense. This proposed direct-DNA-binding mechanism is unconventional and has not been independently characterised outside the Khavinson group.
Russian single-site studies have reported Bronchogen as an adjunct in chronic obstructive pulmonary disease (COPD) and chronic bronchitis in elderly patients, with reported improvements in spirometry and quality-of-life markers versus standard care. These studies are not blinded or placebo-controlled, and no Western Phase 2 or 3 trial has been registered.
Bronchogen has a reported half-life of ~few hours (bioregulator estimate), and the dose intervals researchers model most often fall around once daily. Plasma levels are short-lived with daily dosing, so there is no real buildup. Like other peptide bioregulators, the effect of a course is thought to outlast the dose itself. It is catalogued under Recovery Peptides on WPA.
17 Bronchogen reconstitution calculations have been logged by the WPA community. The most common dose entered is 2mg (5 calculations). The most common bacteriostatic water volume is 3mL. The most popular vial size is 20mg (16 sessions). The most common dosing frequency is daily (7x/week) (1 logged protocols).
These figures come from anonymized WPA peptide calculator sessions.
All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.